A significant contraction in capital deployment characterized October's European tech funding landscape, though the underlying volume of transactions remained largely steady. The month's figures suggest investors are being more selective with deployment rather than pulling back from deal-making altogether. The UK dominated geographically, while the healthtech sector emerged as the primary destination for capital.

October saw European tech companies raise €6 billion through 288 transactions, a substantial drop from September's €15.8 billion across 300 deals. The funding value contracted by approximately 62 per cent month-over-month, while deal count slipped by just 4 per cent, pointing to a divergence between investment frequency and investment size.

The United Kingdom captured €2.6 billion, representing roughly 43 per cent of all European funding. Healthtech claimed the top sector position with €1.3 billion in capital, or 22 per cent of the total, displacing Cloud infrastructure from September's leading position where it had garnered €5.5 billion. Exit activity held steady at 39 transactions throughout the month.

October's figures reveal a market where investment remains concentrated in major deals, but underlying activity is considerably more resilient than the headline decline suggests. This report explores where capital is flowing, which companies are attracting investment and the trends shaping Europe's technology landscape.

Cate Lawrence, Senior Journalist at Tech.eu

The ten largest transactions of October accounted for 51.6 per cent of the month's total funding, underscoring how capital concentration shaped the investment environment.

Source: Tech.eu